Opportunistic Non-Governmental Organisation Delivery of a Virtual Stop Smoking Service in England during the COVID-19 Lockdown.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
23 06 2022
Historique:
received: 10 05 2022
revised: 21 06 2022
accepted: 22 06 2022
entrez: 9 7 2022
pubmed: 10 7 2022
medline: 14 7 2022
Statut: epublish

Résumé

Smoking cessation services have rapidly transformed during the COVID-19 pandemic. Changes include pivoting from face-to-face to telephone and video call support, remote provision of stop smoking aids and more flexible appointments. This study reports an evaluation of a charity-led smoking cessation service rapidly conceived and launched in this context. The pilot service accepted self-referrals in Yorkshire, England from 20 May 2020 to 5 June 2020. A dedicated smoking cessation practitioner provided 12 weeks of weekly behavioural support over telephone or video call. NRT and/or medication and/or e-cigarettes were posted to the participant bi-weekly for up to 12 weeks. Written and telephone evaluation questionnaires were administered post-programme. Of 79 participants, 57 (72.2%) self-reported a 4-week quit and 51 (64.6%) self-reported a 12-week quit. Those concurrently using e-cigarettes and NRT had an 84.1% 12-week quit rate. The majority of participants chose to use e-cigarettes and NRT in combination (55.7%). 39 participants completed an evaluation form, with at least 90% recording they were "very satisfied" with each service component. 27 participants completed a telephone interview, reporting a relationship with practitioners, as well as convenience, and organisational reputation as service strengths. Virtual services can be set up quickly and effectively in response to demand. Quit rates were highest for those concurrently using e-cigarettes and NRT. Service users value flexibility and convenience of remote support and posting of quit aids.

Identifiants

pubmed: 35805380
pii: ijerph19137722
doi: 10.3390/ijerph19137722
pmc: PMC9266272
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/S037519/1
Pays : United Kingdom

Références

Cochrane Database Syst Rev. 2019 May 02;5:CD002850
pubmed: 31045250
Int J Environ Res Public Health. 2022 Apr 20;19(9):
pubmed: 35564394
Contemp Clin Trials. 2018 Nov;74:70-75
pubmed: 30290277
Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):820-2
pubmed: 17416777
Nicotine Tob Res. 2021 May 4;23(5):866-871
pubmed: 33515223
Curr Oncol. 2022 Mar 24;29(4):2263-2271
pubmed: 35448158
Harm Reduct J. 2021 Aug 31;18(1):95
pubmed: 34465346
Addiction. 2022 Mar;117(3):772-783
pubmed: 34431577
Addiction. 2021 May;116(5):1233-1244
pubmed: 33089562
BMJ Open. 2020 Sep 10;10(9):e037086
pubmed: 32912948
JMIR Form Res. 2021 Apr 30;5(4):e25541
pubmed: 33878020
BMJ Open. 2021 Aug 26;11(8):e053075
pubmed: 34446503

Auteurs

Nathan P Davies (NP)

School of Medicine, Nottingham City Hospital, University of Nottingham, Nottingham NG5 1PB, UK.

Matthew E Callister (ME)

Department of Respiratory Medicine, Leeds Teaching Hospitals, Leeds LS1 3EX, UK.

Harriet Copeland (H)

Department of Respiratory Medicine, Leeds Teaching Hospitals, Leeds LS1 3EX, UK.

Stuart Griffiths (S)

Yorkshire Cancer Research, Jacob Smith House, 7 Grove Park Court, Harrogate HG1 4DP, UK.

Leah Holtam (L)

Yorkshire Cancer Research, Jacob Smith House, 7 Grove Park Court, Harrogate HG1 4DP, UK.

Paul Lambert (P)

Yorkshire Cancer Research, Jacob Smith House, 7 Grove Park Court, Harrogate HG1 4DP, UK.

Jacquelyn Mathur (J)

Yorkshire Cancer Research, Jacob Smith House, 7 Grove Park Court, Harrogate HG1 4DP, UK.

Rebecca Thorley (R)

School of Medicine, Nottingham City Hospital, University of Nottingham, Nottingham NG5 1PB, UK.

Rachael L Murray (RL)

School of Medicine, Nottingham City Hospital, University of Nottingham, Nottingham NG5 1PB, UK.
SPECTRUM Consortium, Edinburgh EH8 9AG, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH